Virtual Webinar
Identifying and validating effective cancer targets is a critical step in the development of next-generation therapies. In this upcoming live webinar from Eclipsebio and Active Motif, our experts will share powerful sequencing-based strategies for accelerating cancer target discovery and validation.Dr. Wayne Doyle, Head of Platform at Eclipsebio, will demonstrate how transcriptomic insights can drive cancer drug development from initial target discovery to empirical validation. Dr. Michael Garbati, Epigenetics Services Scientist at Active Motif, will present how multiome analysis can uncover cell subpopulations in cancer samples that may otherwise go undetected.
Click here to register for the event.
Summary
Dates:
April 17, 2025
Location:
Virtual
Topics:
Cancer target discovery and validation